Douyin has been expanding into pharma retail for over three years, and its traffic pool-over 600 million daily active users-is driving explosive category growth. The rise of Douyin’s healthcare business reflects an emerging and important trend: patients’ out of hospital journeys are being reshaped by diversified touchpoints and an expanding volume of online content. Theys now rely on social platforms for disease education and peer stories, use AI tools for quick answers, depend on WOM recommendations, and purchase medicines via e commerce.
This means that for pharma companies entering the out of hospital market, the patient journey must become the starting point for redefining every touchpoint. What role should each platform play-seeding, searching, purchase, or patient management? How should platforms work together? This article uses Douyin as an entry point to explore how public education has evolved across categories-from consumer goods to OTC and prescription medicines.
OTC: Moving First Toward a Consumer-Goods-Style “Seed–Search–Buy” Model
Consumer goods have already achieved a closed-loop “seed-search-buy” model on Douyin. While OTC products can effectively execute “seeding” and “search”, they still cannot convert directly via store/KOC livestreams, or embedded purchase links-leaving a critical “last mile” gap.
Then how can OTC brands deliver efficient patient education under the limited “seed+search” model? Based on category and therapeutic characteristics, flexible strategies could be applied:
01 Comprehensive Communication: From Disease Awareness to Scientific Medication
Disease education can be extended into scientifically grounded category guidance. For example, in the anti hair loss category, different concentrations and formulations serve different patient needs. By explaining how patients of different genders and hair-loss-severity should choose treatment options according to physicians’consultation, brands can help patients build a scientific understanding of disease.
02 Scenario Based Education: Leveraging Hot IPs & Trendy Topics
For acute categories such as cold remedies or stomach medicines, purchase decisions are instant and unplanned. Patients may not fully understand the product-but when the need arises, the brand needs to be immediately recalled. So it is helpful that brands can naturally implant products into scenarios by leveraging popular IPs, trendy topics, or short-drama sponsorships.
03 Synergy Effect: Cross-Category Collaboration Within the Same Brand
Brands that have both OTC and consumer-care SKUs can leverage mature consumer goods operating models for holistic brand-level reach. For example, during a store livestream promoting anti-hair-loss shampoo, the brand can simultaneously integrate disease management education, to direct consumers or patients to their OTC section
Prescription Drugs: From Single Platform to Omnichannel with the Patient Journey as the Anchor
Prescription drugs face stricter compliance requirements. Currently Douyin can only serve as one entry point. The other different platforms-content platforms, interest E-commerce, traditional E-commerce, O2O, and private-domain ecosystems all play different roles across patient journey stages. So the real challenge for pharma brands are how to systematically redesign its out-of-hospital strategy through the perspectives of patient journey.
Patient: How much decision-making power do patients have? How do they gather information? Where do breakpoints occur in the journey?
Platform: What roles can different platforms play? What is the feasible boundary between them?
Business: What are my business issues? What objectives are my patient education?
The patient journey should become the strategic foundation when defining out-of-hospital market planning. Leveraging dual expertise in FMCG+healthcare, cbh(Consumer & Big Health), an Illuminera boutique, has launched a new Patient Engagement Renovation Solution-a framework designed to redefine patient journeys, diagnose core breakpoints, build segment-based pathways, map omni-channel touchpoints and content, and design an integrated patient-communication operating model. The solution helps pharma companies break traditional strategic thinking, shift to a patient first perspective, and unlock new out-of-hospital growth.
For more relevant information, please send an email to marketing@illuminera.com.
